Catheterization News and Research RSS Feed - Catheterization News and Research

Hospital sees success by temporarily connecting major blood vessels

Doctors at Henry Ford Hospital reached a medical milestone April 3, performing the 25th successful transcatheter valve replacement using a novel way to access the heart. [More]
RWJUH offers new alternative to open up blocked arteries

RWJUH offers new alternative to open up blocked arteries

Treatment options for high-risk heart patients with severely calcified coronary artery disease (CAD) have been limited for more than 20 years. Now, Robert Wood Johnson University Hospital offers a new alternative to open up blocked arteries. [More]
Scientists discover how MRP-14 gene generates dangerous clots that could trigger heart attack

Scientists discover how MRP-14 gene generates dangerous clots that could trigger heart attack

Right now, options are limited for preventing heart attacks. However, the day may come when treatments target the heart attack gene, myeloid related protein-14 (MRP-14, also known as S100A9) and defang its ability to produce heart attack-inducing blood clots, a process referred to as thrombosis. [More]
Study of non-surgically implanted replacement pulmonary valve shows strong results

Study of non-surgically implanted replacement pulmonary valve shows strong results

The first post-FDA approval study of a non-surgically implanted replacement pulmonary valve showed strong short- and mid-term results for the device in patients with certain congenital heart defects, according to research presented by a U-M pediatric interventional cardiologist at the American College of Cardiology's 63rd Annual Scientific Session Sunday. [More]
Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C) compared to placebo in patients with high cholesterol. [More]
Newly identified protein markers have potential to contribute to better understanding of heart disease

Newly identified protein markers have potential to contribute to better understanding of heart disease

Researchers at the Intermountain Medical Center Heart Institute in Murray, Utah, have discovered that elevated levels of two recently identified proteins in the body are inflammatory markers and indicators of the presence of cardiovascular disease. [More]

Shortness of breath while bending over is a new heart failure symptom

UT Southwestern Medical Center cardiologists have defined a novel heart failure symptom in advanced heart failure patients: shortness of breath while bending over, such as when putting on shoes. [More]
Amgen announces results from Phase 3 TESLA Trial of evolocumab in patients with HoFH

Amgen announces results from Phase 3 TESLA Trial of evolocumab in patients with HoFH

Amgen (NASDAQ: AMGN) today announced that the Phase 3 TESLA (Trial Evaluating PCSK9 Antibody in Subjects with LDL Receptor Abnormalities) trial evaluating evolocumab met its primary endpoint of the percent reduction from baseline at week 12 in low-density lipoprotein cholesterol (LDL-C). [More]

ATS develops clinical practice guidelines to help clinicians identify, manage patients with sickle cell disease

The American Thoracic Society has developed clinical practice guidelines to help clinicians identify and manage patients with sickle cell disease who are at increased risk for mortality from pulmonary hypertension. [More]

Fujifilm launches latest healthcare technologies at 2014 HIMSS conference and exhibit

FUJIFILM Medical Systems U.S.A., Inc., will be showing several new technologies at the 2014 annual meeting of the Healthcare Informatics Management Systems Society (HIMSS) conference and exhibit in Orlando, FL from February 23-27, 2014. [More]

EU study analyzes effectiveness of cardiac computed tomography

Scientists from 28 research facilities in 20 European countries are meeting today in Berlin to kick off the collaborative research project DISCHARGE. The purpose of this project is to determine for which patients with chest pain cardiac CT or cardiac catheterization is best suited. [More]
St. Joseph's Hospital opens new $20 million Heart Institute

St. Joseph's Hospital opens new $20 million Heart Institute

St. Joseph's Hospital entered the next era of cardiac care by opening a new $20 million Heart Institute on Feb. 10, 2014. St. Joseph's Hospital Heart Institute is one of the most advanced and comprehensive centers for cardiovascular medicine in Florida, performing more than 50,000 adult cardiac catheterizations. It is also has the only pediatric catheterization program in Hillsborough County. [More]

Researchers evaluate trends in cause-specific long-term mortality post PCI

More people who have known coronary heart disease die from other causes — such as cancer, and lung and neurological diseases — than heart disease, compared with 20 years ago, according to a Mayo Clinic study published online today in Circulation, an American Heart Association journal. [More]
Bioengineer receives $1.4M grant to create nanoparticle system to shore up arterial walls

Bioengineer receives $1.4M grant to create nanoparticle system to shore up arterial walls

A UT Arlington bioengineer has received a four-year, $1.4 million National Institutes of Health grant to create a nanoparticle system to shore up arterial walls following angioplasty and stenting procedures to treat coronary arterial disease. [More]

Market research report on prefilled syringe devices and products

Reportlinker.com announces that a new market research report is available in its catalogue: Prefilled Syringe Devices, Products, Markets and Forecasts> [More]

Claret receives CE Mark for Sentinel CPS for embolic protection during aortic valve replacement

Claret Medical, Inc., a developer of innovative solutions for cerebral protection during structural heart interventions, vascular interventions, and cardiac surgery procedures, announced that it has received CE Mark for the Sentinel Cerebral Protection System for embolic protection during Transcatheter Aortic Valve Replacement. [More]
Cystoscopy imperative during female incontinence surgery

Cystoscopy imperative during female incontinence surgery

US researchers say that cystoscopy for lower urinary tract injury should be performed in all women undergoing urinary incontinence surgery, after finding that abnormalities are detected in one in 20 patients. [More]

First commercial implant of Elixir's DESolve Novolimus Eluting Coronary Scaffold performed in Germany

Marking a milestone in the evolution of fully-bioresorbable drug-eluting scaffolds for interventional cardiology, the first commercial implant of Elixir Medical's CE Mark-approved DESolve Novolimus Eluting Coronary Scaffold was performed in Germany by Professor Dr. med. Holger Nef, Head of the Cardiac Catheterization Laboratory, University Hospital Giessen, Giessen, Germany. [More]

LUMEDX contracted to provide comprehensive CVIS to Phoebe Putney Memorial Hospital

LUMEDX Corporation, a leading provider of vendor-neutral cardiovascular imaging and information systems, announced today that it has contracted to provide Phoebe Putney Memorial Hospital with a comprehensive CVIS that will integrate patient data and images across five different sites. The LUMEDX CVIS will consolidate data, improve physician access to patient information, streamline clinical workflows, and support outcomes analysis and registry reporting for the Phoebe Heart and Vascular Center. [More]

Duke LifePoint Healthcare, Wilson Medical Center sign definitive agreement to form joint venture

The Wilson Medical Center Board of Directors has taken the next step in becoming part of Duke LifePoint Healthcare. The organizations have signed a definitive agreement to form a joint venture. The proposed joint venture, which will provide Wilson Medical Center with resources to enhance its services and invest in its growth, is moving forward following a positive vote by the Wilson County Board of Commissioners. The agreement is under review by the Attorney General of North Carolina. [More]